← FDA Drug Approvals (Drugs@FDA)
METATENSIN #2
NDA · New Drug Application · Sponsor: SANOFI AVENTIS US
Drug application
- FDA Application #
NDA012972- Application type
- New Drug Application
- Brand name
- METATENSIN #2
- Generic name
- Reserpine
- Active ingredients
- RESERPINE; TRICHLORMETHIAZIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- SANOFI AVENTIS US
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown